Monday, May 13, 2024 7:58:46 AM
Recent RPHM News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/13/2024 01:38:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:14:11 PM
- Reneo Pharmaceuticals and OnKure Announce Proposed Merger • GlobeNewswire Inc. • 05/13/2024 11:35:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:03:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:00:15 PM
- Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 11:35:00 AM
- Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update • GlobeNewswire Inc. • 03/28/2024 11:35:00 AM
- Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:00:15 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:01:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 02:26:00 PM
- Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 12/14/2023 02:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/22/2023 05:15:05 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 10:08:12 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/13/2023 09:58:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:00:11 PM
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/13/2023 12:35:00 PM
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/02/2023 11:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:47:24 PM
- Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings • GlobeNewswire Inc. • 10/25/2023 11:50:00 AM
- Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 10/09/2023 11:50:00 AM
- Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit • GlobeNewswire Inc. • 10/06/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 09:04:03 PM
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2023 11:35:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM